Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
第一著者: | Hoque, Ismoth Ara |
---|---|
その他の著者: | Azam, Faruque |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2024
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/23164 |
類似資料
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
著者:: Paul, Pulock
出版事項: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
著者:: Rahman, Tasnim
出版事項: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Karim, Samia Binte
出版事項: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024) -
Molecules associated with the development of lung cancer
著者:: Rahman, Adree, 等
出版事項: (2023)